OncoSil Medical (ASX:OSL) received Medical Device Regulation certification from the European Union notified body BSI Group, according to a Tuesday filing with the Australian bourse.
The certification includes the lifting of existing post-market restrictions for the OncoSil cancer treatment device, simplifying the initiation of commercial treatments, the filing said.
The certification also offers the company a chance to re-submit its application to the Therapeutic Goods Administration for Australian market approval, according to the filing.
Oncosil shares surged 20% in recent trade Wednesday.
Price (AUD): $0.01, Change: $+0.0010, Percent Change: +20.00%